- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
May 13, 2021
HIV Vaccine Awareness Day is just around the corner—May 18th! AVAC hosted a webinar, HIV Vaccines in the Midst of COVID, on Thursday, May 13, 2021.
Expert researchers and advocates discussed major issues and advances in HIV vaccine R&D and the impacts of COVID-19 on vaccine research and delivery. The conversation explored the lessons learned to date and how they serve as a warning, a model, and a body of evidence on the need for accelerated vaccine development and comprehensive strategies for equitable global access.
The moderated panel discussion included Barney Graham of the NIH Vaccine Research Center, who helped develop the mRNA vaccine technology; Pontiano Kaleebu of the MRC/UVRI & LSHTM Uganda Research Unit who helps lead the PrEPVacc trial; Linda-Gail Bekker of the Desmond Tutu Health Foundation who is involved in cutting-edge HIV vaccine research and COVID vaccine delivery; and Matthew Rose of Health GAP and Definate Nhamo of PZAT who deal with the wide range of issues of confidence in vaccine research AND delivery.
We hope you’ll enjoy this rich conversation and make the most of your advocacy around HIV Vaccine Awareness Day on May 18.